Portland, OR, Nov. 12, 2019 (GLOBE NEWSWIRE) -- The global opioids market size accounted for $18.53 billion in 2018 and is projected to reach $22.38 billion by 2026, growing at a CAGR of 3.2% during 2019–2026.
Increase in the use of opioids in pain management and a surge in the consumption of opioids in developing countries have boosted the growth of the global opioids market. However, the implementation of stringent government regulation toward vigorous prescription and opioid crisis across the world hamper the market growth. On the contrary, a rise in the consumption of opioids in developing economies is expected to create lucrative opportunities in the near future.
Request Report Sample at https://www.alliedmarketresearch.com/request-sample/3556
The global opioids market is segmented on the basis of product, application, and geography. Based on product, the market is divided into codeine, fentanyl, methadone, oxycodone, morphine, hydrocodone, and others. The oxycodone segment accounted for the largest share in 2018, contributing more than one-fourth of the market. However, the fentanyl segment is projected to register the fastest CAGR of 3.7% during the forecast period.
On the basis of application, the market is bifurcated into pain management, cough treatment, and diarrhea. The pain management segment held the largest share in 2018, accounting for nearly three-fifths of the market. Moreover, the segment is projected to register the fastest CAGR of 2.6% during the forecast period.
The global opioids market is analyzed across various regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America dominated the market in 2018, accounting for nearly half of the market. However, the market across the Asia-Pacific region is estimated to manifest the fastest CAGR of 3.0% during the study period.
Do Purchase Enquiry at https://www.alliedmarketresearch.com/purchase-enquiry/3556
The global opioids market report provides an in-depth analysis of the market players such as
- Pfizer, Inc.
- Purdue Pharma
- Sanofi
- Sun Pharmaceuticals
- Boehringer Ingelheim
- Mallinckrodt Pharmaceuticals
- Allergan, Plc
- Janssen Pharmaceuticals, Inc.
- Endo Pharmaceuticals Inc.
About Us:
Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.